Gemcitabine: all 1,575 studies that test it
Page 8 of 16. Open to participants first (193), then studies with results posted, then the rest; newest registration first within each.
- Alternative Neoadjuvant Chemotherapy in Resectable and Borderline Resectable Pancreatic CancerStatus unknownNCT03703063Phase 1
- High Dose Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic CancerWithdrawnNCT03697239Phase 1/2
- First Line Metastatic Pancreatic Cancer : 5FU/LV+Nal-IRI, Gemcitabine+Nab-paclitaxel or a Sequential Regimen of 2 Months 5FU/LV+Nal-IRICompletedNCT03693677Phase 2
- Evaluation of Symptom Benefit Rate of Trabectedin/PLD in Patients With Recurrent Ovarian CancerTerminatedNCT03690739Phase 3
- Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPCCompletedNCT03673137Phase 2/3
- Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTCCompletedNCT03673072Phase 3
- AZD6738 & Gemcitabine as Combination TherapyStatus unknownNCT03669601Phase 1
- Phase I Nab-Paclitaxel Plus Gemcitabine With Proton Therapy for Locally Advanced Pancreatic Cancer (LAPC)Active, not recruitingNCT03652428Phase 1/2
- Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal CarcinomaStatus unknownNCT03639467Phase 1/2
- SIMPLE Chemotherapy for NK Lymphoma/LeukaemiaStatus unknownNCT03623087Phase 3
- A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI MalignanciesStatus unknownNCT03607643Phase 1/2
- Chidamide Combined With Clad/Gem/Bu With AutoSCT in High Risk Hodgkin & Non-Hodgkin LymphomaStatus unknownNCT03602131Phase 2
- Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory OsteosarcomaActive, not recruitingNCT03598595Phase 1/2
- Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney CancerCompletedNCT03587662Phase 2
- Chemotherapy Before & After Surgery in Patients With Resectable Gallbladder CancerWithdrawnNCT03579758Phase 3
- The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors.CompletedNCT03577704Phase 1/2
- Phase II Umbrella Study Directed by Next Generation SequencingStatus unknownNCT03574402Phase 2
- Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic CancerActive, not recruitingNCT03572400Phase 2
- Locally Advanced or Metastatic Pancreatic AdenocarcinomaCompletedNCT03559348Phase 2
- Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadActive, not recruitingNCT03547973Phase 2
- Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line TreatmentStatus unknownNCT03536780Phase 2
- Scheduling Nab-paclitaxel With GemcitabineCompletedNCT03529175Phase 2
- NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue SarcomaTerminatedNCT03524898Phase 1/2
- CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic CancerCompletedNCT03517176Phase 1
- Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid TumorsCompletedNCT03507491Phase 1
- Study of Brentuximab Vedotin in Patients With R/R PTCL Treated With GemcitabineCompletedNCT03496779Phase 2
- Avelumab/Gemcitabine in Sarcomatoid RCCTerminatedNCT03483883Phase 1
- Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTCCompletedNCT03478488Phase 3
- A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIXTerminatedNCT03450018Phase 1/2
- SLOG vs mFOLFIRINOX as the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic CancerCompletedNCT03443492Phase 2
- A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic CancerStatus unknownNCT03435289Phase 1
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 1
- The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage TherapyStatus unknownNCT03423849Phase 2/3
- Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic CancerCompletedNCT03412799Phase 1
- Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT03406299Phase 2
- Maintenance Chemotherapy in High-metastatic Risk Nasopharyngeal Carcinoma Patients of N3 StageStatus unknownNCT03403829Phase 3
- Carbon Ion Radiation Therapy for Locally Advanced Pancreatic CancerCompletedNCT03403049Phase 1
- The EPIC Trial The Elderly Patient Individualized Chemotherapy TrialStatus unknownNCT03402048Phase 3
- The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic CancerStatus unknownNCT03401827Phase 4
- Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer PatientsWithdrawnNCT03392571Phase 2
- Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPCStatus unknownNCT03366415Phase 3
- Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)CompletedNCT03345810Phase 2
- Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic LeukemiaStatus unknownNCT03339700Phase 2
- Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell LymphomaActive, not recruitingNCT03321643Phase 1
- Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the BladderActive, not recruitingNCT03317158Phase 1/2
- Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic CancerCompletedNCT03316599Phase 1
- Study of PD-1 Inhibitor in Combination With Gemcitabine/Cisplatin for Advancer BTCsStatus unknownNCT03311789Phase 1/2
- Stromal TARgeting for PAncreatic Cancer (STAR_PAC)CompletedNCT03307148Phase 1
- Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer PatientsStatus unknownNCT03278015Phase 2
- Safety and Efficacy of Bendamustine, Gemcitabine, Rituximab, Nivolumab (BeGeRN) in Patients With r/r DLBCLCompletedNCT03259529Phase 1/2
- Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid TumorsCompletedNCT03237390Phase 1
- Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of Pancreatic CancerStatus unknownNCT03236883Phase 1
- Chidamide Combined With Clad/Gem/Bu With AutoSCT in R/R Diffuse Large B Cell LymphomaStatus unknownNCT03151876Phase 2
- A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC SubjectsCompletedNCT03121716Phase 1
- A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder CancerCompletedNCT03093922Phase 2
- Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic CholangiocarcinomaCompletedNCT03079427Phase 2
- Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell LymphomasStatus unknownNCT03071822Phase 4
- A Prospective Study of Neoadjuvant Chemotherapy With Gemcitabine/Platinum in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of BladderStatus unknownNCT03061630Phase 2
- Copanlisib and Gemcitabine in Relapsed/Refractory PTCLCompletedNCT03052933Phase 1/2
- Durvalumab(MEDI4736)/Tremelimumab in Combination With Gemcitabine/Cisplatin in Chemotherapy-naïve Biliary Tract CancerActive, not recruitingNCT03046862Phase 2
- Paediatric Hepatic International Tumour TrialActive, not recruitingNCT03017326Phase 3
- PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast CancerStatus unknownNCT03006614Phase 3
- Mirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast CancerCompletedNCT02996825Phase 1
- Varlitinib in Combination With Gemcitabine and Cisplatin for Treatment naïve Advanced or Metastatic BTCTerminatedNCT02992340Phase 1/2
- Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine GliomaCompletedNCT02992015Early Phase 1
- A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder CancerActive, not recruitingNCT02989584Phase 1/2
- Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed LymphomaWithdrawnNCT02961816Phase 2
- Decitabine and Gemcitabine for Pancreatic Cancer and SarcomaCompletedNCT02959164Phase 1
- Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial BrachytherapyStatus unknownNCT02957266Phase 3
- Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing SurgeryWithdrawnNCT02944357Not applicable
- A Study of Gemcitabine-Carboplatin Plus Necitumumab (LY3012211) in Chemotherapy-Naïve Participants With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)WithdrawnNCT02941601Phase 2
- Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic AdenocarcinomaActive, not recruitingNCT02921022Not applicable
- Neo-adjuvant Chemoradiotherapy Using Infusional Gemcitabine Followed by Surgery for Locally Advanced Rectal CancerStatus unknownNCT02919878Phase 2
- PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early StageStatus unknownNCT02918747Phase 2
- PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic CancerTerminatedNCT02910882Phase 2
- Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder CancerCompletedNCT02885974Phase 1
- Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of PancreascarcinomaStatus unknownNCT02863471Phase 1/2
- A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic CancerStatus unknownNCT02863367Phase 2
- Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell CancerCompletedNCT02860819Phase 2
- Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic CholangiocarcinomaWithdrawnNCT02856568Phase 1
- Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer PatientsCompletedNCT02812992Phase 4
- A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer SubjectsCompletedNCT02797977Phase 1/2
- Vinorelbine and Gemcitabine in MyelomaCompletedNCT02791373Phase 2
- Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical TrailTerminatedNCT02789189Phase 2
- Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader CarcinomaCompletedNCT02778308Not applicable
- Trial of R-GemOx Versus R-miniCHOP Regimen in First-line Treatment of Elderly Diffuse Large B Cell LymphomaStatus unknownNCT02767674Phase 3
- Study of Cytolytic Viral Activation Therapy (CVAT) for Recurrent/Metastatic Nasopharyngeal CarcinomaStatus unknownNCT02761291Phase 1
- Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the PancreasStatus unknownNCT02739633Phase 2
- Study of CG200745 PPA in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic CancerStatus unknownNCT02737228Phase 1/2
- Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With ChemotherapyCompletedNCT02728492Phase 1
- Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the BladderWithdrawnNCT02723838Phase 1
- STUDY 15 - Comparing Gemcitabine/Carboplatin and Hydroxychloroquine Versus Carboplatin/Etoposide Therapy Alone in Small Cell Lung Cancer (SCLC)TerminatedNCT02722369Phase 2
- Phase II Trial for the Treatment of Relapsed OsteosarcomaTerminatedNCT02718482Phase 2
- Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic CancerStatus unknownNCT02717091Phase 2
- Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder CancerStatus unknownNCT02716961Not applicable
- Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002)TerminatedNCT02707328Phase 1
- A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas CancerStatus unknownNCT02707315Early Phase 1
- Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer PatientsCompletedNCT02707159Phase 2
- Belinostat Combined With Azacitidine/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Refractory or Relapsed LymphomaWithdrawnNCT02701673Phase 1/2
- TA(E)C-GP Versus A(E)C-T for the High Risk TNBC Patients and Validation of the mRNA-lncRNA SignatureActive, not recruitingNCT02641847Phase 2/3